These ten mid-cap stocks were the best performers in August. Are they in your portfolio?
- Polestar Automotive Holding (NASDAQ:PSNY) shares jumped 74.19%. It reported strong second-quarter deliveries.
- Upstart Holdings, Inc.’s (NASDAQ:UPST) stock escalated 67.32% after the company reported better-than-expected second-quarter results.
- Lumen Technologies, Inc. (NYSE:LUMN) shares rocketed 58.13%. It reported mixed second-quarter results.
- GDS Holdings Limited (NASDAQ:GDS) shares rose 52.46%. The company reported a better-than-consensus second-quarter loss per share.
- Tempus AI, Inc. (NASDAQ:TEM) stock gained 51.17%. The stock got a boost from investments by Google and SoftBank Group Corp (OTCPK: SFTBF).
- Clear Secure, Inc. (NYSE:YOU) shares were up 46.81%. It reported better-than-expected quarterly results.
- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) stock jumped 42.89%. The company issued upbeat guidance for 2024 and 2025 and better-than-expected second-quarter earnings.
- Evolent Health, Inc. (NYSE:EVH) shares escalated 42.51%. The company initiated an auction process after receiving takeover inquiries from private equity firms and healthcare providers.
- Semtech Corporation (NASDAQ:SMTC) stock rose 42.23%. It reported a second-quarter earnings beat.
- AST SpaceMobile, Inc. (NASDAQ:ASTS) shares grew 42.07%. The company announced that it’s on track to launch five satellites in early September.
Also Read:
- Affirm, Shopify And Starbucks Were Among Top 10 Large Cap Best Performers For August: Are The Others In Your Portfolio?
- Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio?
Photo via Company
PSNYPolestar Automotive Holding UK PLC
$17.27-5.58%
EVHEvolent Health Inc
$3.950.25%
GDSGDS Holdings Ltd
$35.50-1.44%
IOVAIovance Biotherapeutics Inc
$2.25-%
LUMNLumen Technologies Inc
$8.49-0.12%
SFTBFSoftBank Group Corp
$122.5716.1%
SMTCSemtech Corp
$80.17-0.47%
TEMTempus AI Inc
$75.60-0.37%
UPSTUpstart Holdings Inc
$46.30-0.43%
YOUClear Secure Inc
$35.220.27%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
